The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons

Vaccine

Volumn 29, Issue 9, 2011, Pages 1844-1849

  Katayose, Masahiko ^a   Hosoya, Mitsuaki ^b   Haneda, Takashi ^c   Yamaguchi, Hideo ^d   Kawasaki, Yukihiko ^b   Sato, Masatoki ^b,e   Wright, Peter F ^e  

^a Soma General Hospital   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c Haneda Clinic   (Japan)

^d Yamaguchi Children's Clinic   (Japan)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Children; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INFANT; INFECTION CONTROL; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; JAPAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL VARIATION; VACCINATION; VIRUS DETECTION;

EID: 79952696868     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.049     Document Type: Article

References (24)

1. Neuzil KM, Mellen BG, Wright PF, Mitchel Jr EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
2. Shuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6-59 months, 2003-2004. Pediatrics 2007;119:e587-95.
3. Eisenberg KW, Szilagyi PG, Fairbrother G, Griffin MR, Staat M, Shone LP, et al. New Vaccine Surveillance Network. Vaccine effectiveness against laboratory-confirmed influenzainchildren 6-59 monthsofage during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008;122:911-9.
4. Hoberman A,Greenberg DP, Paradise JL, Rockette HE, Lave JR, Kearney DH,etal. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003;290:1608-16.
5. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs. 2 doses. Pediatrics 2005;116:153-9.
6. Allison MA, Daley MF, Crane LA,BarrowJ,BeatyBL, AllredN,etal. Influenza vaccine effectiveness in healthy 6-21-month-old children during the 2003-2004 season. J Pediatr 2006;149:755-62.
7. Jefferson T, Rivetti A, Harnden A, Di Pietrantooj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008:CD004879.
8. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
9. Lewis EN, Griffin MR, Szilagyi PG, Zhu Y, Edwards KM, Poehling KA. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007;120:467-72.
10. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, et al. New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40.
11. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.
12. Edwards KM, Dupont WD, Westrich MK, Plummer Jr WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
13. Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, Newton DW, et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008;198:312-7.
14. Fiore AE, Shay DK, Broder K,Iskander JK, Uyeki TM, Mootrey G, etal. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57:1-60.
15. Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004;23:138-44.
16. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, et al. CAIV-T Comparative Efficacy Study Group Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685-96.
17. Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, et al. Pan-Asian CAIV-T Pediatric Efficacy Trial Network. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007;26:619-28.
18. Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, et al. CAIV-T Pediatric Day Care Clinical Trial Network. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006;118:2298-312.
19. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889-96.
20. Monto AS, Davenport FM, Napier JA, Francis Jr T. Modification ofan outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970;122:16-25.
21. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007;120:e553-64.
22. King Jr JC, Stoddard JJ, Gaglani MJ, Moore KA, Magder L, McClure E, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006;355:2523-32.
23. Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990;144:595-600.
24. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Rotavirus Efficacy and Safety Trial (REST) Study Team. the Rotavirus Efficacy and Safety Trial Study Team. Safety and efficacy of a pentava-lent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33.